Bristol-Myers Squibb Co. (NYSE:BMY)

The valuation ratios exhibit distinct trends over the observed period. Generally, a decreasing trend is apparent across most ratios from March 2022 through December 2023, followed by some degree of fluctuation and, in some cases, increases into the forecast period ending December 2025. This suggests a shifting perception of the company’s value relative to its financial performance.

Price to Earnings (P/E) Ratio

The Price to Earnings ratio decreased consistently from 25.64 in March 2022 to 12.27 in December 2023. A subsequent increase is observed, reaching 17.30 by December 2025. This initial decline may indicate increasing earnings relative to the stock price, or a decrease in investor confidence. The later increase suggests a renewed, though not complete, return to higher valuation multiples.

Price to Operating Profit (P/OP) Ratio

Similar to the P/E ratio, the Price to Operating Profit ratio demonstrates a downward trend from 20.32 in March 2022 to 13.53 in December 2023. The ratio then rises to 12.20 in December 2025, but remains below levels seen in the earlier part of the period. This pattern mirrors the P/E ratio, indicating a relationship between earnings and operating profitability and market valuation.

Price to Sales (P/S) Ratio

The Price to Sales ratio shows a pronounced decline from 3.41 in March 2022 to 2.19 in December 2023. The ratio then experiences volatility, reaching 2.53 in December 2025. This suggests a significant change in how the market values each dollar of revenue generated by the company. The recent increase could be due to anticipated revenue growth or a change in market sentiment.

Price to Book Value (P/BV) Ratio

The Price to Book Value ratio also decreased from 5.07 in March 2022 to 3.35 in December 2023. A notable increase is then observed, peaking at 6.98 in December 2024 before settling at 6.61 in December 2025. This indicates a changing perception of the company’s net asset value and its relationship to the market price of its shares. The increase in later periods suggests a re-evaluation of the company’s underlying asset base.

Overall, the observed trends suggest a period of valuation compression followed by a degree of stabilization and, in some cases, modest recovery. The consistent declines in the ratios through December 2023 warrant further investigation into the underlying drivers of these changes, while the subsequent fluctuations require continued monitoring to assess the sustainability of any emerging trends.

The price-to-earnings (P/E) ratio exhibited a consistent decline from March 31, 2022, through December 31, 2023, followed by a period of fluctuation and eventual increase. This movement correlates with changes in both share price and earnings per share (EPS) over the observed period.

Overall Trend

From a high of 25.64 in March 2022, the P/E ratio generally decreased to a low of 12.27 by December 2023. This indicates that the market was valuing each dollar of earnings at a progressively lower multiple. Subsequently, the P/E ratio began to rise, reaching 17.30 by December 2025, suggesting a renewed investor confidence or expectation of future earnings growth.

Phase 1: Declining P/E (March 2022 – December 2023)

During this phase, the P/E ratio decreased from 25.64 to 12.27. This decline was driven by a combination of factors. While share price decreased from US$75.27 to US$48.71, EPS also experienced fluctuations but ultimately increased from US$2.94 to US$3.97. The greater decrease in share price relative to the increase in EPS contributed to the declining P/E ratio.

Phase 2: Fluctuating and Increasing P/E (March 2024 – December 2025)

From March 2024 through June 2024, the P/E ratio is not available due to negative EPS values. Following this period, the P/E ratio began to recover, moving from 18.29 in March 2025 to 17.30 in December 2025. This recovery coincided with a rise in share price from US$48.69 to US$59.93 and an increase in EPS from US$2.66 to US$3.46. The increase in both share price and EPS contributed to the rising P/E ratio.

Impact of Negative Earnings

The period from March 2024 to June 2024 is characterized by negative EPS values, resulting in an undefined P/E ratio. Negative earnings typically render the P/E ratio meaningless, as it represents a loss rather than a profit. This period likely reflects a temporary downturn in profitability.

In summary, the P/E ratio demonstrated a clear downward trend followed by a recovery, influenced by the interplay between share price and EPS. The period of negative earnings significantly impacted the ratio's interpretability, and the subsequent recovery suggests a potential shift in market sentiment or improved financial performance.

The Price to Operating Profit (P/OP) ratio exhibited a generally decreasing trend over the observed period, with notable fluctuations. Initially, the ratio demonstrated a decline from 20.32 to 13.53 between March 31, 2022, and December 31, 2023. Following this, the ratio experienced a period of volatility, with an absence of reported values for the first four quarters of 2024. A subsequent increase is observed, culminating in a ratio of 12.20 by December 31, 2025.

Overall Trend

From the beginning of the period to the end of 2023, the P/OP ratio generally decreased. This suggests that the market valuation relative to operating profit was becoming more compressed. The subsequent period shows some recovery, but remains below the initial values.

Initial Decline (2022-2023)

The decline in the P/OP ratio from 20.32 to 13.53 can be attributed to a combination of factors. The share price decreased from US$75.27 to US$48.71 during this period, while operating profit per share remained relatively stable, fluctuating between US$3.60 and US$4.19. This indicates that investor sentiment shifted, leading to a lower valuation of each dollar of operating profit.

Period of Unavailable Data (2024)

The lack of reported P/OP ratios for the first four quarters of 2024 warrants further investigation. The absence of this metric hinders a complete understanding of the company’s valuation during this time. The operating profit per share became negative during this period, which explains the lack of a P/OP ratio calculation.

Recent Recovery (2025)

The P/OP ratio increased to 12.20 by December 31, 2025, driven by a rise in the share price to US$59.93 and a corresponding increase in operating profit per share to US$4.91. This suggests a potential improvement in investor confidence and a renewed willingness to pay a higher premium for each dollar of operating profit. The ratio remains below the levels observed at the beginning of the analyzed period.

In summary, the P/OP ratio demonstrates a complex pattern of decline, interruption, and partial recovery. The period of unavailable values requires additional scrutiny, and the recent increase, while positive, does not fully restore the ratio to its earlier levels.

The price-to-sales ratio exhibited a consistent downward trend from March 31, 2022, through December 31, 2023, before demonstrating some volatility and a subsequent increase through December 31, 2025. This analysis details the observed patterns and potential implications.

Overall Trend

From a value of 3.41 in March 2022, the price-to-sales ratio generally decreased to a low of 2.19 by December 2023. This represents a significant contraction over approximately two years. Following this decline, the ratio experienced fluctuations, reaching 2.53 by the end of the observed period in December 2025.

Initial Decline (March 2022 - December 2023)

The period between March 2022 and December 2023 saw a steady reduction in the price-to-sales ratio. The decline was not precipitous, but consistent, moving from 3.41 to 2.19. This suggests a decreasing investor willingness to pay for each dollar of sales during this timeframe, potentially reflecting concerns about future growth or profitability.

Volatility and Recovery (March 2024 - December 2025)

Beginning in March 2024, the ratio showed increased volatility. It rose to 2.38 in September 2024, then decreased to 1.85 in June 2025, before recovering to 2.53 by December 2025. This period indicates a potential shift in market sentiment or a response to company-specific events. The final increase suggests a renewed, albeit moderate, investor confidence.

Sales per Share

Throughout the observed period, sales per share demonstrated a generally increasing trend, moving from 22.06 in March 2022 to 23.67 in December 2025. This upward trajectory in sales per share contrasts with the initial decline in the price-to-sales ratio, suggesting that the ratio’s decrease was primarily driven by changes in the share price rather than fundamental sales performance.

Ratio Relationship

The observed movements in the price-to-sales ratio appear inversely related to the share price. As the share price decreased from March 2022 to December 2023, the ratio also declined. The subsequent fluctuations and eventual increase in the ratio align with the share price’s volatility and recovery during the latter part of the period.

In conclusion, the price-to-sales ratio experienced a notable decline followed by a period of volatility and partial recovery. The trend appears to be more closely linked to share price movements than to changes in sales per share.

The price to book value (P/BV) ratio exhibited a generally declining trend from March 31, 2022, through December 31, 2023, before showing increased volatility and a subsequent rise. A significant shift in the ratio occurred beginning in March 2024, with values increasing through December 2024, followed by a decrease and then a substantial increase by December 31, 2025.

Overall Trend

From March 31, 2022 (5.07) to December 31, 2023 (3.35), the P/BV ratio demonstrated a consistent downward trajectory, indicating a decreasing market valuation relative to the company’s book value. This suggests investors were becoming less willing to pay a premium for the net asset value of the company during this period. The ratio then began to increase, reaching 6.61 by December 31, 2025.

Initial Decline (2022-2023)

The initial decline from 5.07 in March 2022 to 3.35 in December 2023 was relatively steady, with minor fluctuations. This period saw a decrease of approximately 34% in the P/BV ratio. The share price decreased more rapidly than the book value per share during this time, contributing to the decline.

Shift and Volatility (2024-2025)

Beginning in March 2024, the P/BV ratio experienced a notable shift. It increased from 5.49 to a peak of 6.98 in December 2024, before decreasing to 5.70 in March 2025. The ratio then increased significantly to 6.61 by December 31, 2025. This period demonstrates increased volatility compared to the prior period, suggesting changing investor sentiment or expectations. The book value per share also experienced fluctuations, but the share price changes were more pronounced, driving the ratio’s volatility.

Book Value Per Share (BVPS) Influence

The book value per share remained relatively stable between March 2022 and September 2023, fluctuating between approximately US$14.25 and US$15.37. A more substantial decrease was observed in March 2024 (US$8.13), which likely contributed to the initial increase in the P/BV ratio. BVPS then increased again, reaching US$9.07 by December 2025. The interplay between share price and BVPS was the primary driver of the P/BV ratio’s movements.

In summary, the P/BV ratio experienced a period of decline followed by increased volatility and a subsequent rise. The fluctuations appear to be driven by a combination of changes in share price and book value per share, indicating shifts in market perception and underlying financial performance.